Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
634.00    20.00 (3.26%)
Bid:
627.00
Ask:
628.00
Spread: 1.00 (0.159%)
Market Cap: £767.37m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Oxford Biomedica News

London close: Blue chips falter after recent strength
15 Oct 2009

London close: Blue chips falter after recent strength

London closed lower as bumper profits at US investment bank Goldman Sachs failed to spark Wall Street, which has retreated from the 10,000 mark hit la...

London afternoon: Stocks stuck in red
15 Oct 2009

London afternoon: Stocks stuck in red

Bumper profits at US investment bank Goldman Sachs have failed to ignite fresh buying interest on Wall Street, leaving London weaker as resource plays...

TechMARK movers: Oxford Bio jumps on trial
15 Oct 2009

TechMARK movers: Oxford Bio jumps on trial

Oxford Biomedica doubled at one stage Thursday after it said patients taking part in a Phase I/II trial of its Parkinson's disease drug ProSavin have ...

London midday: Sainsbury's soars on Qatar rumours
15 Oct 2009

London midday: Sainsbury's soars on Qatar rumours

J Sainsbury is the stand-out riser so far on talk that the Qatar investors in the supermarket are looking to build on their current 26% stake, but it ...

Oxford Biomedica doubles on Parkinson's success
15 Oct 2009

Oxford Biomedica doubles on Parkinson's success

Oxford Biomedica doubled at one stage Thursday after it said patients taking part in a Phase I/II trial of its Parkinson's disease drug ProSavin have ...

TechMARK movers: Oxford Bio down after update
22 Sep 2009

TechMARK movers: Oxford Bio down after update

Shares in Oxford BioMedica dropped after interim results from a Phase III study of the gene therapy company's cancer vaccine TroVax did not show a 'si...

TechMARK movers: GB and Oxford Biomedica drop
13 Jul 2009

TechMARK movers: GB and Oxford Biomedica drop

Identity management specialists GB Group was slightly lower despite saying that interim pre-tax profit was marginally ahead of the same period last ye...

TechMARK movers: Alizyme chief exec steps down
6 Jul 2009

TechMARK movers: Alizyme chief exec steps down

Alizyme has lost chief executive Tim McCarthy as part of the drug developer's reconstruction effort. Non-executive director Alan Goodman will take ch...